SURG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
SurgePays Inc (SURG) is not a strong buy at the moment for a beginner investor with a long-term focus. The technical indicators are neutral to bearish, the financial performance shows significant challenges, and there are no strong positive catalysts or trading signals to justify immediate investment. Holding off for now and monitoring for improved fundamentals or technical signals is recommended.
The MACD is slightly positive but contracting, suggesting weakening momentum. RSI is neutral at 45.086, indicating no clear trend. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading below key pivot levels, with support at 0.513 and resistance at 0.692. Overall, the technical outlook is weak.
The company reported a 68.67% YoY increase in revenue for Q4 2025, indicating growth potential in top-line performance.
Net income dropped by 30.03% YoY, EPS fell by 62.38%, and gross margin plummeted by 87.59%, reflecting significant financial challenges. No recent news or congress trading data to act as a positive catalyst. Analysts have lowered the price target from $9.75 to $5, citing weaker Q4 revenue.
In Q4 2025, revenue increased by 68.67% YoY to $16,187,007. However, net income dropped to -$13,862,120 (-30.03% YoY), EPS fell to -0.38 (-62.38% YoY), and gross margin declined to -14.92% (-87.59% YoY). The financials indicate growth in revenue but severe profitability and margin challenges.
Analysts maintain a Buy rating but have significantly lowered the price target from $9.75 to $5, citing weaker Q4 revenue but expecting a growth rebound in 2026.
